Unitree’s August 19 STAR Market debut changed the evidence environment more than it changed the deployment case. The company raised about RMB 6.1 billion in its IPO, and its shares closed at RMB 845, compared with an offering price of RMB 150.80. Reuters put the resulting market value at about $50 billion. At IPO pricing, Unitree had been valued at roughly RMB 61 billion, or $9 billion. In the interval between pricing and the first-day close, the equity valuation increased more than fivefold without a comparable change in publicly verified evidence of sustained customer operation.
For investors, the more durable development is that Unitree is now inside a listed-company disclosure regime. Financial performance, changes in business mix, profitability and other material disclosures can increasingly be tracked against the commercial narrative rather than reconstructed mainly from private-company announcements.
Unitree already brings financial evidence that is unusual in humanoid robotics. Reuters reported 2025 revenue of about RMB 1.7 billion and adjusted net profit of about RMB 600 million. Humanoid robots generated RMB 867.8 million, making them the company’s largest revenue segment. But they represented about 52% of revenue, meaning Unitree is not a pure humanoid business. Its quadruped robots, components and other activities remain material.
The valuation has moved faster than the operating evidence
The first-day valuation illustrates the size of the expectation now embedded in Unitree’s equity.
Using the approximately 404.5 million post-offering shares implied by the IPO structure and the RMB 845 closing price gives an equity value of about RMB 342 billion. Compared with RMB 867.8 million of disclosed 2025 humanoid revenue, that is roughly 394 times the humanoid segment’s annual revenue.
That is not a conventional revenue multiple. The numerator values the whole company, while the denominator includes only humanoid revenue. It is better treated as an illustrative comparison showing how far the public valuation has moved ahead of the current humanoid revenue base.
The evidence boundary is equally important. Unitree’s prospectus says the company shipped more than 5,500 humanoid robots in 2025. That establishes substantial product volume, but shipment does not establish customer operation. Reuters reported after the listing that many Unitree robots are sold to research institutions and that commercial application remains limited.
What Unitree’s new disclosure regime can establish over time is therefore as important as the IPO itself. Investors can watch whether humanoid revenue continues to expand, how margins change, whether customer concentration becomes clearer and whether financial disclosures begin to show stronger industrial demand.
Those filings still may not answer the harder deployment questions. Public evidence does not yet provide sufficiently broad customer-confirmed data on tasks, operating hours, uptime, human intervention, productivity, economics or repeat deployment.
Humanoid Analytics treats Unitree’s IPO as a confirmed closed funding event. It does not change a deployment Evidence Score.
The next meaningful evidence is a connection between Unitree’s demonstrated sales volume and repeat operating work. If named customers begin confirming sustained deployments and measurable results, Unitree’s new public-company transparency should make that commercial progression easier to track. Until then, the listing provides a stronger financial benchmark than a deployment benchmark.
Sources:
- Reuters, “Unitree surges in Shanghai debut, a milestone for China’s humanoid robotics sector”
Source type: Tier 2, strong independent evidence
https://www.reuters.com/world/asia-pacific/chinese-humanoid-robot-maker-unitree-set-jump-over-600-shanghai-debut-2026-08-19/ - Reuters, “Chinese humanoid robot maker Unitree prices IPO at $9 billion valuation”
Source type: Tier 2, strong independent evidence
https://www.reuters.com/world/asia-pacific/chinese-robot-maker-unitree-prices-shanghai-ipo-2026-08-06/ - Unitree Technology Co., Ltd., “宇树科技股份有限公司首次公开发行A股股票并在科创板上市招股说明书”
Source type: Tier 1, direct or official evidence, company-controlled regulatory filing
https://static.sse.com.cn/stock/disclosure/announcement/c/202603/002178_20260320_QY8F.pdf